Comparing Health-Care Providers' Perspectives on Complementary and Alternative Medicine in Childhood Cancer Between Netherlands and Indonesia

1. Stefanus Gunawan MD, MSc¹,
2. Marijn Arnoldussen MSc²,
3. Maartje S. Gordijn MD, PhD²,
4. Mei N. Sitaresmi MD, PhD³,
5. Peter M. van de Ven MSc, PhD⁴,
6. Chloé A.M. ten Broeke MSc²,
7. Anjo J.P. Veerman MD, PhD²,
8. Max Mantik MD, PhD¹,
9. Gertjan J.L. Kaspers MD, PhD² and
10. Saskia Mostert MD, PhD^2,*

Article first published online: 14 AUG 2015

DOI: 10.1002/pbc.25689

© 2015 Wiley Periodicals, Inc.

Issue

Pediatric Blood & Cancer

Volume 63, Issue 1, pages 118–123, January 2016

Keywords:

• complementary alternative medicine;
• health-care providers;
• perspectives

Background

Use of complementary and alternative medicine (CAM) is common among patients with childhood cancer. Health-care providers (HCP) should address this need properly. Geographical and cultural differences seem likely. This study explores perspectives on CAM of HCP involved in the care of children with cancer in Netherlands and Indonesia. Health beliefs, components of CAM, encouraging or discouraging CAM, and knowledge about CAM were assessed.

Procedure

We conducted a cross-sectional study using semi-structured questionnaires at a Dutch and Indonesian academic hospital.

Results

A total of 342 HCP participated: 119 Dutch (response rate 80%) and 223 Indonesian (response rate 87%). Chemotherapy can cure cancer according to more Dutch than Indonesian HCP (87% vs. 53% respectively, P  < 0.001). Combination of chemotherapy and CAM is the best way to cure cancer according to more Indonesian than Dutch HCP (45% vs. 25%, P  < 0.001). Dutch and Indonesian HCP recommend and discourage CAM use differently. Most Dutch (77%) and Indonesian HCP (84%) consider their knowledge about CAM to be inadequate (P = ns). Fewer Dutch doctors than other HCP want to learn more about CAM (51% vs. 76%, P  = 0.007), whereas there is no significant difference in eagerness to learn about CAM between Indonesian doctors (64%) and other HCP (72%).

Conclusions

Indonesian HCP have more positive views about CAM than their Dutch colleagues. Both Dutch and Indonesian HCP consider their knowledge about CAM to be inadequate. Therefore, education programs about CAM tailored to the needs of HCP are recommended, knowing that CAM is used frequently. Pediatr Blood Cancer © 2015 Wiley Periodicals, Inc.